Coagulation dysregulation as a barrier to xenotransplantation in the primate

Transplant Immunology

Volumn 21, Issue 2, 2009, Pages 75-80

  Lin, Chih Che ^a,b,c   Cooper, David K C ^b   Dorling, Anthony ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Coagulation; Pig; Platelets; Primate; Xenotransplantation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CD39 ANTIGEN; CLOPIDOGREL; EPTIFIBATIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; MEVINOLIN; REGULATOR PROTEIN; SIMVASTATIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; WARFARIN;

ADD ON THERAPY; ANEMIA; APOPTOSIS; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; ENDOTHELIUM CELL; GENETIC ENGINEERING; GRAFT RECIPIENT; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNE INJURY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; ORGAN TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; REVIEW; SWINE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOSIS; TRANSGENIC PIG; TRANSGENICS; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD COAGULATION; BLOOD PLATELETS; CELL COMMUNICATION; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; GRAFT REJECTION; HUMANS; LEUKOCYTES; PRIMATES; SWINE; THROMBOPLASTIN; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 67349190309     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.10.008     Document Type: Review

References (60)

1. Cooper D.K., Gollackner B., and Sachs D.H. Will the pig solve the transplantation backlog. Annu Rev Med 53 (2002) 133-147
2. Cooper D.K., Dorling A., Pierson III R.N., Rees M., Seebach J., Yazer M., et al. Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here. Transplantation 84 (2007) 1-7
3. Mackman N. Tissue-specific hemostasis: role of tissue factor. J Thromb Haemost 6 (2008) 303-305
4. Schulte Am Esch II J., Robson S.C., Knoefel W.T., Hosch S.B., and Rogiers X. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 12 (2005) 30-37
5. Kopp C.W., Grey S.T., Siegel J.B., McShea A., Vetr H., Wrighton C.J., et al. Expression of human thrombomodulin cofactor activity in porcine endothelial cells. Transplantation 66 (1998) 244-251
6. Siegel J.B., Grey S.T., Lesnikoski B.A., Kopp C.W., Soares M., Schulte am Esch II J., et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 64 (1997) 888-896
7. Roussel J.C., Moran C.J., Salvaris E.J., Nandurkar H.H., d'Apice A.J., and Cowan P.J. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 8 (2008) 1101-1112
8. Kopp C.W., Siegel J.B., Hancock W.W., Anrather J., Winkler H., Geczy C.L., et al. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 63 (1997) 749-758
9. Lee K.F., Salvaris E.J., Roussel J.C., Robson S.C., d'Apice A.J., and Cowan P.J. Recombinant pig TFPI efficiently regulates human tissue factor pathways. Xenotransplantation 15 (2008) 191-197
10. Chen D., Weber M., McVey J.H., Kemball-Cook G., Tuddenham E.G., Lechler R.I., et al. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am J Transplant 4 (2004) 1958-1963
11. Mendicino M., Liu M., Ghanekar A., He W., Koscik C., Shalev I., et al. Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. Circulation 112 (2005) 248-256
12. Chen D., Carpenter A., Abrahams J., Chambers R.C., Lechler R.I., McVey J.H., and Dorling A. Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med. 205 8 (2008)
13. Crikis S., Cowan P.J., and d'Apice A.J. Intravascular thrombosis in discordant xenotransplantation. Transplantation 82 (2006) 1119-1123
14. Cowan P.J. Coagulation and the xenograft endothelium. Xenotransplantation 14 (2007) 7-12
15. Cowan P.J., and d'Apice A.J. The coagulation barrier in xenotransplantation: incompatibilities and strategies to overcome them. Curr Opin Organ Transplant 13 (2008) 178-183
16. van der Windt D.J., Bottino R., Casu A., Campanile N., and Cooper D.K. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14 (2007) 288-297
17. Cowan P.J., Aminian A., Barlow H., Brown A.A., Chen C.G., Fisicaro N., et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 69 (2000) 2504-2515
18. Menoret S., Plat M., Blancho G., Martinat-Botte F., Bernard P., Karam G., et al. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. Transplantation 77 (2004) 1468-1471
19. Shimizu A., Yamada K., Yamamoto S., Lavelle J.M., Barth R.N., Robson S.C., et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 16 (2005) 2732-2745
20. Chen G., Qian H., Starzl T., Sun H., Garcia B., Wang X., et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 11 (2005) 1295-1298
21. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11 (2005) 32-34
22. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299 (2003) 411-414
23. Tseng Y.L., Kuwaki K., Dor F.J., Shimizu A., Houser S., Hisashi Y., et al. Alpha1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80 (2005) 1493-1500
24. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
25. Shimizu I., Smith N.R., Zhao G., Medof E., and Sykes M. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies. Transplantation 81 (2006) 95-100
26. Kelishadi S.S., Zhang T., Stoddard T., Azimzadeh A.M., Welty E., Avon C.J., et al. Addition of HDAF to the Gal-KO background improved survival and function of pig kidneys in baboons. Am J Transplant 8 (2008) 205
27. Gollackner B., Goh S.K., Qawi I., Buhler L., Knosalla C., Daniel S., et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 77 (2004) 1735-1741
28. Saethre M., Baumann B.C., Fung M., Seebach J.D., and Mollnes T.E. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Transplantation 84 (2007) 244-250
29. Pearson J.D. Endothelial cell function and thrombosis. Baillieres Best Pract Res Clin Haematol 12 (1999) 329-341
30. Bach F.H., Robson S.C., Ferran C., Winkler H., Millan M.T., Stuhlmeier K.M., et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev (1994) 141, 5-30
31. Ghanekar A., Mendicino M., Liu H., He W., Liu M., Zhong R., et al. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 172 (2004) 5693-5701
32. Robson S.C., Kaczmarek E., Siegel J.B., Candinas D., Koziak K., Millan M., et al. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185 (1997) 153-163.
33. Khalpey Z., Yuen A.H., Kalsi K.K., Kochan Z., Karbowska J., Slominska E.M., et al. Loss of ecto-5′nucleotidase from porcine endothelial cells after exposure to human blood: implications for xenotransplantation. Biochim Biophys Acta 1741 (2005) 191-198
34. Imai M., Takigami K., Guckelberger O., Enjyoji K., Smith R.N., Lin Y., et al. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med 5 (1999) 743-752
35. Koyamada N., Miyatake T., Candinas D., Hechenleitner P., Siegel J., Hancock W.W., et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 62 (1996) 1739-1743
36. Dwyer K.M., Mysore T.B., Crikis S., Robson S.C., Nandurkar H., Cowan P.J., et al. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation 82 (2006) 428-432
37. Dwyer K.M., Robson S.C., Nandurkar H.H., Campbell D.J., Gock H., Murray-Segal L.J., et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113 (2004) 1440-1446
38. Kim Y.T., Lee H.J., Lee S.W., Kim J.Y., Wi H.C., Park S.J., et al. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation. Xenotransplantation 15 (2008) 27-35
39. Cantu E., Balsara K.R., Li B., Lau C., Gibson S., Wyse A., et al. Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. Am J Transplant 7 (2007) 66-75
40. Morrell C.N., Sun H., Swaim A.M., and Baldwin III W.M. Platelets an inflammatory force in transplantation. Am J Transplant 7 (2007) 2447-2454
41. Dorsam R.T., and Kunapuli S.P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 1131 (2004) 340-345
42. Wagner D.D., and Frenette P.S. The vessel wall and its interactions. Blood 111 (2008) 5271-5281
43. Holzknecht Z.E., Kuypers K.L., Plummer T.B., Williams J., Bustos M., Gores G.J., et al. Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 91 (2002) 1135-1141
44. Shimizu A., Hisashi Y., Kuwaki K., Tseng Y.L., Dor F.J., Houser S.L., et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 172 (2008) 1471-1481.
45. Bombeli T., Karsan A., Tait J.F., and Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood 89 (1997) 2429-2442
46. Fisicaro N., d'Apice A.J., and Cowan P.J. Efficient co-expression of multiple graft-protective transgenes using the 2A. Xenotransplantation 14 4 (2007) 383
47. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (1996) 1001-1009
48. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. Jama 279 (1998) 1615-1622
49. LaRosa J.C. Pleiotropic effects of statins and their clinical significance. Am J Cardiol 88 (2001) 291-293
50. Palinski W. New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol 21 (2001) 3-5
51. Ezzelarab M., and Cooper D.K. The potential of statins in xenotransplantation. Xenotransplantation 14 (2007) 100-103
52. Colli S., Eligini S., Lalli M., Camera M., Paoletti R., and Tremoli E. Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 17 (1997) 265-272
53. Aikawa M., Rabkin E., Sugiyama S., Voglic S.J., Fukumoto Y., Furukawa Y., et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103 (2001) 276-283
54. Eto M., Kozai T., Cosentino F., Joch H., and Luscher T.F. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105 (2002) 1756-1759
55. Ledoux S., Laouari D., Essig M., Runembert I., Trugnan G., Michel J.B., et al. Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases. Circ Res 90 (2002) 420-427
56. Chan A.W., Moliterno D.J., Berger P.B., Stone G.W., DiBattiste P.M., Yakubov S.L., et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol 42 (2003) 1188-1195.
57. Gurbel P.A., Bliden K.P., Zaman K.A., Yoho J.A., Hayes K.M., and Tantry U.S. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation 111 (2005) 1153-1159
58. Schirmer J.M., Fass D.N., Byrne G.W., Tazelaar H.D., Logan J.S., and McGregor C.G. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival. Xenotransplantation 11 (2004) 436-443
59. Candinas D., Lesnikoski B.A., Robson S.C., Miyatake T., Scesney S.M., Marsh Jr. H.C., et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 62 (1996) 336-342
60. Alwayn I.P., Appel J.Z., Goepfert C., Buhler L., Cooper D.K., and Robson S.C. Inhibition of platelet aggregation in baboons: therapeutic implications for xenotransplantation. Xenotransplantation 7 (2000) 247-257